# A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber

> **NCT02481856** · PHASE2 · COMPLETED · sponsor: **ALK-Abelló A/S** · enrollment: 219 (actual)

## Conditions studied

- Allergic Rhinoconjunctivitis

## Interventions

- **DRUG:** SQ tree SLIT-tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02481856
- **Lead sponsor:** ALK-Abelló A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 219 (ACTUAL)
- **Last updated:** 2017-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02481856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02481856, "A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02481856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*